Read More: To view or add a comment, sign in GLP-1 Medications and Vision: A Rare but Important Safety Signal GLP-1 receptor agonists, including semaglutide and tirzepatide, have transformed the management of type 2 diabetes and obesity by improving glycaemic control, promoting weight loss, and reducing cardiovascular risk
Allergic reactions, although rare, can also occur and would require immediate medical attention
Diarrhea, constipation, and decreased appetite beyond the therapeutic effect also occur frequently
Finamore A, Palmery M, Bensehaila S, Peluso I
2006;6:33 Krishnan A, Schneider CV, Hadi Y, Mukherjee D, AlShehri B, Alqahtani SA